-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – JAB-3312 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - JAB-3312 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. JAB-3312 in Solid Tumor Drug Details: JAB-3312 is under development for...
-
Product Insights
NewOpium (Opioid) Addiction – Drugs In Development, 2024
Empower your strategies with our Opium (Opioid) Addiction – Drugs In Development, 2024 report and make more profitable business decisions. Opioid addiction develops after using opioids regularly for a period of time. Prolonged use of opiates can lead to nerve damage within the brain that causes cells to stop producing endogenous opiates (natural painkillers, known as endorphins). This can lead to an inability of the body to stop pain, because there are no endorphins to mask the pain initially. The degeneration...
-
Product Insights
NewAnaphylaxis – Drugs In Development, 2024
Empower your strategies with our Anaphylaxis – Drugs In Development, 2024 report and make more profitable business decisions. Anaphylaxis is a severe, potentially life-threatening allergic reaction. Anaphylaxis symptoms include dizziness, nausea, vomiting or diarrhea, feeling of warmth, constriction of the airways, and a swollen tongue or throat. Risk factors include personal history of anaphylaxis, allergies or asthma, and family history. Treatment includes beta-agonists, antihistamines, and cortisone. The Anaphylaxis drugs in development market research report provide comprehensive information on the therapeutics under...
-
Product Insights
NewAcute Opioid Overdosage – Drugs In Development, 2024
Empower your strategies with our Acute Opioid Overdosage – Drugs In Development, 2024 report and make more profitable business decisions. Opioids are common treatment strategy for treating pain. Drug abuse is commonly seen with opioids as these are habit forming drugs or by misuse. Opioid overdose occurs when opioid medications are taken in larger quantities irrespective of the prescribed amount. Overdosage stimulates the opiate pathway leading to decreased respiratory function and death. Common causes are prescription error, misuse that can be...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Nalmefene in Acute Opioid Overdosage
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Nalmefene in Acute Opioid Overdosage report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nalmefene in Acute Opioid Overdosage Drug Details: Nalmefene (OX-125) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Naloxone in Acute Opioid Overdosage
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Naloxone in Acute Opioid Overdosage report and make more profitable business decisions. How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ETH-155008 in Refractory Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ETH-155008 in Refractory Acute Myeloid Leukemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.ETH-155008 in Refractory Acute Myeloid Leukemia Drug Details:ETH-155008 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BRESCAP in Acute Renal Failure (ARF) (Acute Kidney Injury)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BRESCAP in Acute Renal Failure (ARF) (Acute Kidney Injury) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.BRESCAP in Acute Renal Failure (ARF) (Acute Kidney...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ketorolac in Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ketorolac in Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Ketorolac in PainDrug Details:Ketorolac is under development for the treatment of moderate to moderately...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – APVO-436 in Relapsed Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - APVO-436 in Relapsed Acute Myeloid Leukemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.APVO-436 in Relapsed Acute Myeloid LeukemiaDrug Details:APVO-436 is under development for...